Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Multiomic analysis for minimal residual disease detection: Addressing challenges in stage II-III colon cancer from COSMOS-CRC-01.
Authors
Yoshiaki Nakamura
Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan
Yoshiaki Nakamura , Yuichiro Tsukada , Nobuhisa Matsuhashi , Tatsuro Murano , Manabu Shiozawa , Takeshi Kato , Eiji Oki , Masahiro Goto , Yoshinori Kagawa , Akiyoshi Kanazawa , Takashi Ohta , Akira Ouchi , Hideaki Bando , Hiroshi Uchigata , Chiemi Notake , Mingyang Cai , Shile Zhang , Thereasa A. Rich , Kimberly Banks , Takayuki Yoshino
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 180)
DOI
10.1200/JCO.2024.42.3_suppl.180
Abstract #
180
Poster Bd #
L8
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
INTERCEPT Program of circulating tumor DNA (ctDNA) testing for minimal residual disease (MRD) in colorectal cancer (CRC): Results from a prospective clinical cohort.
First Author: Giulia Maddalena
Poster
2023 ASCO Annual Meeting
Association of positive ctDNA-based minimal residual disease assays during surveillance and undiagnosed concomitant radiographic recurrences in colorectal cancer (CRC): Results from the MD Anderson INTERCEPT program.
First Author: Arvind Dasari
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Circulating tumor DNA (ctDNA) informs clinical practice in patients with recurrent/metastatic gastroesophageal cancers.
First Author: Rutika Mehta
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Plasma-only multiomic minimal residual disease (MRD) testing in 2,000 consecutive patients with colorectal cancer (CRC).
First Author: Katrina Sophia Pedersen